Your browser doesn't support javascript.
loading
A multi-dimensional, time-lapse, high content screening platform applied to schistosomiasis drug discovery.
Chen, Steven; Suzuki, Brian M; Dohrmann, Jakob; Singh, Rahul; Arkin, Michelle R; Caffrey, Conor R.
Afiliación
  • Chen S; Department of Pharmaceutical Chemistry and Small Molecule Discovery Center, University of California, San Francisco, CA, 94143, USA.
  • Suzuki BM; Center for Discovery and Innovation in Parasitic Diseases, Department of Pathology, University of California, San Francisco, CA, 94158, USA.
  • Dohrmann J; Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, 92093, USA.
  • Singh R; Department of Computer Science, San Francisco State University, San Francisco, CA, 94132, USA.
  • Arkin MR; Department of Computer Science, San Francisco State University, San Francisco, CA, 94132, USA. rahul@sfsu.edu.
  • Caffrey CR; Department of Pharmaceutical Chemistry and Small Molecule Discovery Center, University of California, San Francisco, CA, 94143, USA. michelle.arkin@ucsf.edu.
Commun Biol ; 3(1): 747, 2020 12 21.
Article en En | MEDLINE | ID: mdl-33349640
ABSTRACT
Approximately 10% of the world's population is at risk of schistosomiasis, a disease of poverty caused by the Schistosoma parasite. To facilitate drug discovery for this complex flatworm, we developed an automated high-content screen to quantify the multidimensional responses of Schistosoma mansoni post-infective larvae (somules) to chemical insult. We describe an integrated platform to process worms at scale, collect time-lapsed, bright-field images, segment highly variable and touching worms, and then store, visualize, and query dynamic phenotypes. To demonstrate the methodology, we treated somules with seven drugs that generated diverse responses and evaluated 45 static and kinetic response descriptors relative to concentration and time. For compound screening, we used the Mahalanobis distance to compare multidimensional phenotypic effects induced by 1323 approved drugs. Overall, we characterize both known anti-schistosomals and identify new bioactives. Apart from facilitating drug discovery, the multidimensional quantification provided by this platform will allow mapping of chemistry to phenotype.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Schistosoma / Esquistosomicidas / Esquistosomiasis mansoni / Evaluación Preclínica de Medicamentos / Descubrimiento de Drogas Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: Commun Biol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Schistosoma / Esquistosomicidas / Esquistosomiasis mansoni / Evaluación Preclínica de Medicamentos / Descubrimiento de Drogas Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: Commun Biol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos